The fourth patient with diffuse midline glioma had wildtype histone H3.1 and H3.3, and on genomic sequencing, had mutations in PIK3CA conserved C2 domain, TP53 DNA binding domain, and a ASXL1 truncation mutation with loss of DNA binding domain. The gene discussed is TP53; the disease is diffuse midline glioma.